22nd August 2018
Three out of nine winners of the European Health Catapult Finals are French start-ups.
After the grand finale that took place in Lodz, the winners of the European Health Catapult Business Plan Competition – in the three categories of Biotech, Medtech and Digital Health – were chosen by a professional jury following pitches by 22 finalists for the EIT Health Summit audience.
EIT Health France is very proud to announce that the three French candidates of the European Health Catapult won a final prize.
1st Prize – MedTech Category
Aenitis – Their technologies patented medical devices for continuous, contactless and pressurless sorting of cells in suspensions, to address the challenges of cell therapy units and blood banks in cell sorting, cell washing and on cell isolation for blood, tissues and stem cells processing.
2nd Prize – MedTech Category
VitaDX – International innovative medical device for early bladder cancer diagnosis combines fluorescence imaging and image processing using machine learning algorithms to detect cancerous cells in a urine sample.
3rd Prize – Digital Health category
Feet Me– A connected insole and an associated mobile software that collects and analyses gait spatio-temporal parameters and variability. The innovation is designed to improve mobility outcomes and home rehabilitation through smart active wearable technology.
Click here to learn more about the initial start-ups chosen during the European Health Catapult French Selection.
EIT Health helps Tubulis secure €10.7M in funding
Investor Network aids firm doing antibody work
EIT Health-backed start-ups garner big investments
A million each for iLoF and Restorative Neurotechnologies
EIT Health aids 11 start-ups disrupted by COVID-19
Start-up Rescue Instrument gives €5.5M in co-investment